Hox-Regulated MSCs in Skeletal Development, Growth and Fracture Healing

Hox 调节的 MSC 在骨骼发育、生长和骨折愈合中的作用

基本信息

  • 批准号:
    10566127
  • 负责人:
  • 金额:
    $ 45.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-08 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Although the critical roles Hox genes play in establishing skeletal morphology has been known for decades, virtually nothing is understood regarding the molecular mechanisms by which Hox genes function in the skeleton. Utilizing a unique collection of genetic tools that permit live visualization of Hox expression (Hoxa11eGFP), Cre-mediated lineage labeling and/or conditional deletion (HoxCreERT2, Hoxd11LoxP/LoxP) and assessment of Hox11 chromatin binding sites (unpublished, validated Hoxa113XFLAG and Hoxd113XFLAG alleles), the overall objective of this application is to dissect the pathways and targets regulated by Hox transcription factors in skeletal stem/progenitor cells to regulate osteogenic and chondrogenesis differentiation. Previous work has demonstrated that Hox-expressing stem/progenitors are maintained in the skeleton in the absence of Hox function, and osteo- and chondrogenic lineages continue to emerge (Sox9-, Osx-/Runx2-expressing), but differentiation is incomplete. Osteoblasts do not progress to mature stages, and chondrocytes fail to undergo normal apoptosis and replacement by bony matrix in Hox mutants. This differentiation defect can be recapitulated in vitro. Based on previously published work and preliminary data, the central hypothesis is that Hox transcription factors regulate critical downstream events at the top of the hierarchy during osteochondrogenic differentiation from skeletal stem/progenitor cells in parallel with canonical differentiation factors. This project will utilize the Hoxa11eGFP reporter and Hoxa11CreERT2-mediated lineage labeling in the presence and absence of adult conditional deletion of Hoxd11 to probe the single cell trajectories of Hox11- expressing progenitors as they expand and differentiate into cartilage and bone in response to injury (Aim 1). The recapitulation of osteo- and chondrogenic differentiation defects in Hox11 mutants in vitro permits a comparative assessment of differential gene expression during temporally controlled differentiation (Aim 2). Newly generated and validated Hoxa113XFLAG; Hoxd113XFLAG epitope-tagged alleles will be utilized to interrogate the sites of chromatin binding in Hox-expressing progenitors and early differentiating cells (Aim 3). The research proposal is innovative in its use of sophisticated genetic tools generated by the research team, the combined in vivo and in vitro approaches, and critical inclusion of a co-investigator and her team with biostatistics expertise. The proposed research is significant as it addresses the longstanding and highly significant question of the molecular mechanism of Hox function in the skeleton. As Hox expression is only observed in skeletal stem/progenitors and early differentiation markers initiate as cells exit the Hox lineage, dissecting the downstream targets and pathways regulated by Hox that are critical to complete successful osteogenic and chondrogenic differentiation will provide impactful new knowledge of skeletal biology.
项目总结/摘要 尽管Hox基因在建立骨骼形态中的关键作用已经被认为是 几十年来,几乎没有什么是了解的分子机制,Hox基因的功能,在 骨架。利用独特的遗传工具集合,允许Hox表达的实时可视化 (Hoxa 11 eGFP)、Cre介导的谱系标记和/或条件性缺失(HoxCreERT 2、Hoxd 11 LoxP/LoxP)和 评估Hox 11染色质结合位点(未发表、经验证的Hoxa 113 XFLAG和Hoxd 113 XFLAG等位基因), 本申请的总体目标是剖析Hox转录调控的途径和靶点 因子在骨骼干/祖细胞调节成骨和软骨分化。先前 工作已经证明,表达Hox的干/祖细胞在缺乏Hox的情况下维持在骨骼中。 Hox功能,骨和软骨形成谱系继续出现(Sox 9-,Osx-/Runx 2-表达),但 分化是不完全的。成骨细胞不能进展到成熟阶段,软骨细胞不能经历 Hox突变体中正常的细胞凋亡和骨基质替代。这种分化缺陷可能是 体外重现。基于先前发表的工作和初步数据,中心假设是, Hox转录因子在转录过程中调节位于层级顶部的关键下游事件。 骨干/祖细胞向骨软骨细胞的分化与典型分化平行 因素该项目将利用Hoxa 11 eGFP报告基因和Hoxa 11 CreERT 2介导的谱系标记, 存在和不存在Hoxd 11的成人条件性缺失,以探测Hox 11- 表达祖细胞,因为它们响应于损伤而扩增并分化成软骨和骨(Aim 1)。 Hox 11突变体体外成骨和软骨分化缺陷的重演允许 在时间控制分化期间差异基因表达的比较评估(目的2)。 新生成并验证的Hoxa 113 XFLAG; Hoxd 113 XFLAG表位标记的等位基因将用于询问 在表达Hox的祖细胞和早期分化细胞中染色质结合的位点(Aim 3)。的 这项研究计划是创新的,它使用了研究小组开发的复杂的遗传工具, 结合体内和体外方法,并关键纳入了一名联合研究者和她的团队, 生物统计学专业知识。拟议的研究是重要的,因为它解决了长期和高度 Hox在骨骼中功能的分子机制的重要问题。由于Hox表达式仅 在骨骼干细胞/祖细胞中观察到,早期分化标志物在细胞退出Hox谱系时开始, 剖析下游目标和Hox调控的途径,这是完成成功的关键, 成骨和成软骨分化将为骨骼生物学提供有影响力的新知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deneen M Wellik其他文献

Deneen M Wellik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deneen M Wellik', 18)}}的其他基金

Hox-Regulated MSCs in Skeletal Development, Growth and Fracture Healing
Hox 调节的 MSC 在骨骼发育、生长和骨折愈合中的作用
  • 批准号:
    10840553
  • 财政年份:
    2022
  • 资助金额:
    $ 45.76万
  • 项目类别:
Hox-Regulated MSCs in Skeletal Development, Growth and Fracture Healing
Hox 调节的 MSC 在骨骼发育、生长和骨折愈合中的作用
  • 批准号:
    10662574
  • 财政年份:
    2022
  • 资助金额:
    $ 45.76万
  • 项目类别:
Hox genes regulate functionally distinct, regionally restricted MSC populations
Hox 基因调节功能不同、区域受限的 MSC 群体
  • 批准号:
    10197314
  • 财政年份:
    2019
  • 资助金额:
    $ 45.76万
  • 项目类别:
Hox5 gene regulation of lung fibroblasts and distal lung extracellular matrix
Hox5基因对肺成纤维细胞和远端肺细胞外基质的调控
  • 批准号:
    9980992
  • 财政年份:
    2018
  • 资助金额:
    $ 45.76万
  • 项目类别:
Hox5 gene regulation of lung fibroblasts and distal lung extracellular matrix
Hox5基因对肺成纤维细胞和远端肺细胞外基质的调控
  • 批准号:
    10202716
  • 财政年份:
    2018
  • 资助金额:
    $ 45.76万
  • 项目类别:
Hox-Expressing Stromal Cells in Muscle Development and Repair
表达 Hox 的基质细胞在肌肉发育和修复中的作用
  • 批准号:
    9530540
  • 财政年份:
    2017
  • 资助金额:
    $ 45.76万
  • 项目类别:
Using BMSC-derived Bone-Ligament-Bone Tissue as a Live Template for ACL Regenerat
使用 BMSC 衍生的骨韧带骨组织作为 ACL 再生的实时模板
  • 批准号:
    8490317
  • 财政年份:
    2012
  • 资助金额:
    $ 45.76万
  • 项目类别:
Using BMSC-derived Bone-Ligament-Bone Tissue as a Live Template for ACL Regenerat
使用 BMSC 衍生的骨韧带骨组织作为 ACL 再生的实时模板
  • 批准号:
    8383131
  • 财政年份:
    2012
  • 资助金额:
    $ 45.76万
  • 项目类别:
Role of Hox Genes in Integration of the Musculoskeletal System in Development
Hox 基因在发育中肌肉骨骼系统整合中的作用
  • 批准号:
    8308416
  • 财政年份:
    2011
  • 资助金额:
    $ 45.76万
  • 项目类别:
Role of Hox Genes in Integration of the Musculoskeletal System in Development
Hox 基因在发育中肌肉骨骼系统整合中的作用
  • 批准号:
    8840889
  • 财政年份:
    2011
  • 资助金额:
    $ 45.76万
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 45.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
  • 批准号:
    10334113
  • 财政年份:
    2022
  • 资助金额:
    $ 45.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了